| Tirapazamine: from bench to clinical trials L Marcu, I Olver Current clinical pharmacology 1 (1), 71-79, 2006 | 132 | 2006 |
| Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials L Marcu, E Bezak, BJ Allen Critical reviews in oncology/hematology 123, 7-20, 2018 | 115 | 2018 |
| A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment LG Marcu, E Yeoh Journal of cancer research and clinical oncology 135, 1303-1314, 2009 | 98 | 2009 |
| Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer L Marcu, T van Doorn, I Olver Acta oncologica 42 (4), 315-325, 2003 | 87 | 2003 |
| Biomedical physics in radiotherapy for cancer L Marcu, E Bezak, B Allen Csiro publishing, 2012 | 68 | 2012 |
| Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status R Takam, E Bezak, LG Marcu, E Yeoh Radiation Research 176 (4), 508-520, 2011 | 62 | 2011 |
| Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain LG Marcu Cancer Treatment Reviews 36 (8), 606-614, 2010 | 57 | 2010 |
| Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers PA Reid, P Wilson, Y Li, LG Marcu, E Bezak Head & neck 39 (9), 1920-1932, 2017 | 55 | 2017 |
| Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas L Marcu, T Van Doorn, I Olver Physics in Medicine & Biology 49 (16), 3767, 2004 | 50 | 2004 |
| The impact of COVID‐19 pandemic on gender‐related work from home in STEM fields—Report of the WiMPBME Task Group M Frize, L Lhotska, LG Marcu, M Stoeva, G Barabino, F Ibrahim, S Lim, ... Gender, Work & Organization 28, 378-396, 2021 | 49 | 2021 |
| Solutions to gender balance in STEM fields through support, training, education and mentoring: report of the international women in medical physics and biomedical engineering … G Barabino, M Frize, F Ibrahim, E Kaldoudi, L Lhotska, L Marcu, M Stoeva, ... Science and engineering ethics 26, 275-292, 2020 | 49 | 2020 |
| Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach L Marcu, E Bezak, I Olver Physics in Medicine & Biology 51 (15), 3625, 2006 | 42 | 2006 |
| Gender-dependent radiotherapy: The next step in personalised medicine? L De Courcy, E Bezak, LG Marcu Critical Reviews in Oncology/Hematology 147, 102881, 2020 | 39 | 2020 |
| Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy LG Marcu, L Moghaddasi, E Bezak International Journal of Radiation Oncology* Biology* Physics 102 (4), 1165-1182, 2018 | 38 | 2018 |
| Translational research in FLASH radiotherapy—from radiobiological mechanisms to in vivo results LG Marcu, E Bezak, DD Peukert, P Wilson Biomedicines 9 (2), 181, 2021 | 36 | 2021 |
| Risk of second primary cancer after breast cancer treatment LG Marcu, A Santos, E Bezak European Journal of Cancer Care 23 (1), 51-64, 2014 | 36 | 2014 |
| Current challenges in clinical target volume definition: tumour margins and microscopic extensions L Moghaddasi, E Bezak, LG Marcu Acta Oncologica 51 (8), 984-995, 2012 | 36 | 2012 |
| In silico modelling of treatment-induced tumour cell kill: Developments and advances LG Marcu, WM Harriss-Phillips Computational and Mathematical Methods in Medicine 2012, 2012 | 33 | 2012 |
| Risk estimation of second primary cancers after breast radiotherapy AMC Santos, LG Marcu, CM Wong, E Bezak Acta Oncologica 55 (11), 1331-1337, 2016 | 32 | 2016 |
| Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models R Takam, E Bezak, EE Yeoh, L Marcu Medical physics 37 (9), 5126-5137, 2010 | 32 | 2010 |
eva bezakcancer research institute, University of South AustraliaVerified email at optusnet.com.au
